Kynam Global Healthcare Master Fund, LP insider trades: 2seventy bio (TSVT) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kynam Global Healthcare Master Fund, LP reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 11, 2025 | TSVT | ↓ Sell | 11,095,936 | $4.93 | $54.7M | Indirect | Mar 13, 2025 (2d) |
| Mar 11, 2025 | TSVT | ↓ Sell | 5,142,111 | $4.93 | $25.4M | Direct | Mar 13, 2025 (2d) |
| Aug 10, 2023 | TSVT | ↑ Buy | 515,414 | $5.92 | $3.0M | Indirect | Aug 16, 2023 (6d) |
| Aug 10, 2023 | TSVT | ↑ Buy | 86,414 | $5.96 | $515K | Direct | Aug 16, 2023 (6d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Kynam Global Healthcare Master Fund, LP's insider trades
Kynam Global Healthcare Master Fund, LP is a 10% owner of 2seventy bio (TSVT). Since Aug 10, 2023, it has reported 2 open-market purchases worth $3.6M and 2 sales worth $80.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TSVT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.